Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study

NCT07462559 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT07462559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07462559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
March 4, 2026
Completion date
December 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug drug interaction